Last reviewed · How we verify

NCT04593108

Misoprostol With or Without Letrozole in Treatment of Missed Miscarriage

Status unknown Last updated 20 October 2020
What this trial tests

trial testing Letrozole misoprostol in Missed Abortion in 320 participants. Status unknown.

Timeline
15 January 2019
Primary endpoint
1 October 2020
15 November 2020

Quick facts

Lead sponsorDr.Dalia Mohammed Al Sayed Zaki
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment320
Start date15 January 2019
Primary completion1 October 2020
Estimated completion15 November 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Dr.Dalia Mohammed Al Sayed Zaki

Who can join

Adults 18 to 35, female only, with Missed Abortion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of study Compare the success rate of misoprostol with versus without letrozole as a pretreatment for medical termination of pregnancy during the first trimester. Hypothesis: Letrozole value as a pre-treatment medication for misoprostol in induction of abortion during the first trimester. Research question: Will letrozole- misoprostol protocol give better results than misoprostol- alone protocol in induction of abortion during the first trimester?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Missed Abortion

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04593108.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing